Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112294
Status:
COMPLETED
Last Update Posted:
2015-12-24
First Post:
2005-06-01
Brief Title:
Study of TaxaneCarboplatin - Cetuximab as First-Line Treatment for Patients With AdvancedMetastatic Non-Small Cell Lung Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Small-Cell Lung Carcinoma |
Keywords:
| Name | View |
|---|---|
| Non-Small Cell Lung Cancer | View |